BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. (BPTH)

About BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. (BPTH)

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.

BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. News